☆ 4.7 Review

The Effects of Bortezomib on Bone Disease in Patients With Multiple Myeloma

CANCER (2014)

Get Full Text
Add to Collection

Journal

CANCER
Volume 120, Issue 5, Pages 618-623

Publisher

WILEY
DOI: 10.1002/cncr.28481

Keywords

-

Categories

Oncology

Funding

  1. Celgene
  2. Janssen
  3. Association for Training, Education and Research in Hematology, Immunology and Transplantation (ATERHIT)
  4. (Hospital Clinical Research Program, PHRC) from the French National Cancer Institute (INCa)
  5. Janssen-Cilag
  6. Amgen
  7. Novartis

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available
Webinars Posters Questions Hubs Funding Journals Papers Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.